Suzanne CadaretteSuzanne M. Cadarette, BSc, MSc, PhD
Lead, AHRQ Pharmacy Smoking Cessation Descriptive Project
Lead, AHRQ Pharmacy Smoking Cessation Program 2.0
Member, MedsCheck and Pharmaceutical Opinion Program project
Member, Pharmacists as immunizers project
Member, Mapping health geography data and pharmacy access

Suzanne is a member of three OPEN projects — the MedsCheck and Pharmaceutical Opinion Program project, a study that’s assessing the effectiveness of several current pharmacist service programs, the Pharmacists as immunizers project, a study that’s evaluating the effectiveness and uptake of influenza vaccination in pharmacies, a recent service community pharmacists can provide to their patients, and the Mapping health geography data and pharmacy access project, an OPEN study that is examining the geographic distribution of community pharmacies relative to the residential concentrations of vulnerable populations.

Suzanne was also the lead of a now-completed applied health research question that examined the effectiveness of Ontario’s Pharmacy Smoking Cessation Program, as well as the lead of the next phase of research on that program.

These OPEN projects make use of healthcare use and administrative claims data housed at ICES — the Institute for Clinical Evaluative Sciences. Suzanne brings to OPEN her expertise in health services research and pharmacoepidemiology, along with her experience as the Pharmacy Lead, ICES University of Toronto.

Suzanne is an Associate Professor of Pharmacy at the University of Toronto, a Senior Adjunct Scientist at ICES, the Pharmacy Lead, ICES University of Toronto, and Graduate Coordinator, Department of Pharmaceutical Sciences, University of Toronto.

She completed her undergraduate training in the Faculty of Applied Health Sciences at the University of Waterloo, an MSc in epidemiology at the Dalla Lana School of Public Health, and a PhD in health services research from the Institute of Health Policy, Management and Evaluation, both at the University of Toronto. She completed postdoctoral training in pharmacoepidemiology with the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women’s Hospital, Harvard Medical School.

Suzanne is a consultant with Osteoporosis Canada’s Scientific Advisory Council, a mentor in the Drug Safety and Effectiveness Cross-disciplinary Training Program, and an active member of the WHO Collaborating Centre for Governance, Transparency and Accountability in the Pharmaceutical Sector, the American Society for Bone and Mineral Research, and the International Society for Pharmacoepidemiology.

Q&A with Suzanne